FX-322 in Adults With Severe Sensorineural Hearing Loss
NCT04629664
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Hearing Loss, Sensorineural
Noise Induced Hearing Loss
Sudden Hearing Loss
Interventions
DRUG:
FX-322
OTHER:
Placebo
Sponsor
Frequency Therapeutics